Interventional oncologic therapies are increasingly applied in many types of cancer in particular, the so-called "solid tumors" originating from the lung, liver, pancreas, breast, colon, kidney, soft tissue and bone as well as their metastases.
In contrast, solid tumors originating from the nerve tissue such as the brain and spinal cord, or "hollow" organs such as the stomach and intestine are not well suited for interventional oncological treatments with some exceptions.
Since interventional oncologic treatments are local or regional therapies that have very little systemic effect, they are not suitable in solid tumors with wide spread metastases or in hematologic cancers such as leukemia and lymphoma that commonly attact the whole body.
Interventional oncology in cancer management
Prof Saim Yilmaz, MD